PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,300,746 | +15.8% | 83,300 | -3.6% | 0.05% | +25.0% |
| Q1 2023 | $1,987,200 | +333.9% | 86,400 | +49.2% | 0.04% | +233.3% |
| Q2 2022 | $458,000 | -88.8% | 57,923 | -66.5% | 0.01% | -87.4% |
| Q1 2022 | $4,095,000 | +808.0% | 172,941 | +1210.2% | 0.10% | +763.6% |
| Q4 2021 | $451,000 | +176.7% | 13,200 | -42.7% | 0.01% | -21.4% |
| Q1 2020 | $163,000 | +79.1% | 23,039 | +78.7% | 0.01% | +75.0% |
| Q4 2019 | $91,000 | -84.5% | 12,893 | -73.7% | 0.01% | -85.2% |
| Q3 2019 | $588,000 | -54.2% | 48,972 | -53.8% | 0.05% | -53.8% |
| Q2 2019 | $1,283,000 | +857.5% | 105,965 | +432.0% | 0.12% | +485.0% |
| Q4 2018 | $134,000 | – | 19,917 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |